Kohlberg Kravis Roberts & Co. L.P. has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $2.37 Billion distributed in 70 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bridge Bio Pharma, Inc. with a value of $960M, Bright View Holdings, Inc. with a value of $603M, Property Guru Group LTD with a value of $165M, Transphorm, Inc. with a value of $120M, and Endeavor Group Holdings, Inc. with a value of $116M.

Examining the 13F form we can see an decrease of $470M in the current position value, from $2.84B to 2.37B.

Kohlberg Kravis Roberts & Co. L.P. is based out at New York, NY

Below you can find more details about Kohlberg Kravis Roberts & Co. L.P. portfolio as well as his latest detailed transactions.

Portfolio value $2.37 Billion
Healthcare: $1.02 Billion
Industrials: $603 Million
Real Estate: $266 Million
Communication Services: $231 Million
Technology: $148 Million
Financial Services: $90.4 Million
Energy: $6.81 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 70
  • Current Value $2.37 Billion
  • Prior Value $2.84 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 8 stocks
  • Additional Purchases 11 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 23 stocks
Track This Portfolio

Track Kohlberg Kravis Roberts & Co. L.P. Portfolio

Follow Kohlberg Kravis Roberts & Co. L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kohlberg Kravis Roberts & Co. L.P., based on Form 13F filings with the SEC.

News

Stay updated on Kohlberg Kravis Roberts & Co. L.P. with notifications on news.